Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
0.3901
Dollar change
+0.0352
Percentage change
9.92
%
Index- P/E- EPS (ttm)-0.16 Insider Own51.21% Shs Outstand9.38M Perf Week-18.15%
Market Cap6.65M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.32M Perf Month-16.49%
Enterprise Value3.58M PEG- EPS next Q- Inst Own1.08% Short Float0.21% Perf Quarter-29.56%
Income-2.41M P/S21.45 EPS this Y- Inst Trans0.38% Short Ratio0.01 Perf Half Y-56.29%
Sales0.31M P/B1.41 EPS next Y- ROA-74.52% Short Interest0.02M Perf YTD-7.30%
Book/sh0.28 P/C2.07 EPS next 5Y- ROE-101.64% 52W High32.00 -98.78% Perf Year-86.91%
Cash/sh0.19 P/FCF- EPS past 3/5Y- - ROIC-50.99% 52W Low0.32 21.56% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y-13.92% - Gross Margin84.99% Volatility20.01% 26.46% Perf 5Y-
Dividend TTM- EV/Sales11.55 EPS Y/Y TTM-431.48% Oper. Margin-831.07% ATR (14)0.09 Perf 10Y-
Dividend Ex-Date- Quick Ratio11.36 Sales Y/Y TTM-46.67% Profit Margin-790.57% RSI (14)41.38 Recom-
Dividend Gr. 3/5Y- - Current Ratio11.69 EPS Q/Q-589.34% SMA20-22.21% Beta5.65 Target Price-
Payout- Debt/Eq0.03 Sales Q/Q-67.93% SMA50-23.48% Rel Volume0.02 Prev Close0.35
Employees- LT Debt/Eq0.00 Earnings- SMA200-91.69% Avg Volume1.34M Price0.39
IPOSep 05, 2024 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume31,153 Change9.92%
iTonic Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.